Objective-To study the association of PAF-acetyl hydrolase (PAFAH) activity with inflammation, oxidative stress, and atherosclerosis in hypercholesterolemic swine. Methods and Results-Cholesterol-rich diet feeding of miniature pigs was associated with an increase in PAFAH activity and an increase of the PAFAH to PON1 ratio. PLA2G7 RNA (coding for PAFAH) expression was increased in blood monocytes and plaque macrophages. Increased PAFAH activity was associated with higher plasma lysophosphatidylcholine and correlated with oxidized LDL. In THP1 monocytes and macrophages and in human blood-derived macrophages, oxidized LDL induced PLA2G7 RNA expression. Atherogenic diet feeding induced the accumulation of macrophages and oxidized LDL in the arterial wall leading to atherosclerosis. PAFAH activity correlated positively with plaque size and TNFalpha expression in plaque macrophages. Conclusions-We demonstrated that an increase in PAFAH activity was associated with increased levels of lysophosphatidylcholine, oxidized LDL, and inflammation, resulting in accelerated atherosclerosis in hypercholesterolemic minipigs. The significant correlation between PLA2G7 RNA expression in plaque macrophages and plasma PAFAH activity suggests that the latter is a consequence, rather than a cause of macrophage accumulation. Our cell experiments suggest that oxidized LDL can induce PAFAH, resulting in accumulation of lysophosphatidylcholine that increases the inflammatory action of oxidized LDL.
I
t is clear that inflammation and oxidative stress are associated with cardiovascular diseases and underlying atherosclerosis. [1] [2] [3] [4] Blood monocytes and plaque macrophages play a key role in the onset and development of the inflammatory reaction by generating bioactive molecules, such as platelet-activating-factor (PAF), in response to a variety of stimuli. 5, 6 Oxidative stress is closely associated with the inflammatory response and bioactive lipid formation. Oxidation of LDL results in the formation of oxidized phospholipids and PAF-like molecules, which are potent bioactive lipids contributing to inflammation. 7 The uptake of oxidized LDL (oxLDL) by macrophages results in the formation of lipidloaded foam cells. In a later stage, macrophage-rich areas are more prone to disruption, leading to thrombus formation and consequently to acute coronary syndromes. 8 HDL, in contrast to oxLDL, protects against atherosclerosis because of its antiinflammatory and antioxidant properties. 9 ,10 HDL-associated paraoxonase-1 (PON1) is the primary enzyme responsible for the antiinflammatory and antioxidant activities of HDL. 11 Purified human PON1 decreases the accumulation of lipoperoxides in LDL thus preventing LDL oxidation. 12 In addition, PON1 reduces the ability of oxLDL to induce monocyte binding and transmigration and thereby inflammation in the vessel wall. 13 However, if PON1 fails to prevent the oxidation of LDL, oxidized phospholipids become substrate for platelet-activating factoracetylhydrolase (PAFAH, also termed Lp-PLA2 or PLA2G7) which is associated with both HDL and LDL. Because PAFAH degrades PAF and PAF-like molecules produced on inflammation and LDL oxidation, it is proposed to exert an antiatherogenic role. 14 Mouse 15, 16 and rabbit [17] [18] [19] data support the protective role of PAFAH. In contrast, in humans PAFAH was found to indicate angiographic coronary artery disease independently of systemic inflammation and other risk factors. 20 On hydrolysis of PAF and oxidized phospholipids, PAFAH generates lysophospholipids such as lysophosphatidylcholine (LPC) and oxidized free fatty acids which are deleterious to the vessel wall. PAF and oxidized phospholipids are active at concentrations several-fold lower as compared to those of lysophospholipids, suggesting that the equilibrium between the degradation and generation of proatherogenic phospholipids may favor the antiatherogenic or proatherogenic role of PAFAH. 14 Therefore, our aim was to study the association of PAFAH activity with inflammation and oxidative stress in a hypercholesterolemic swine model for atherosclerosis. Previously, we have shown the relevance of this model for studying the relation of oxidative stress and inflammation in atherosclerosis. 21 Furthermore, because PON1 inhibits the formation and accumulation of the PAFAH substrates and PAFAH may possess a dual pro-and antiinflammatory role depending on the concentration and the availability of the potential substrates, we hypothesize that a high PAFAH to PON1 ratio is associated with increased atherosclerosis.
Materials and Methods

Animal Procedures
Animal experiments were performed conform to the Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85-23, revised 1996). The Institutional Review Board of the KU Leuven approved all animal procedures. Miniature pigs were bred and maintained as described previously. [22] [23] [24] Pigs (nϭ21) were fed an atherogenic diet, containing 4% cholesterol, 14% beef tallow, and 2% hog bile, administered at an amount of 1 kg/d starting at the age of 4 months: 6 for 6 weeks; 4 for 12 weeks, 5 for 24 weeks and 6 for 36 weeks. Age and weight-matched (at start) control pigs (nϭ14) were on standard chow.
Blood Analysis
Peripheral venous blood from pigs was drawn from an ear vein. Serum and EDTA-plasma samples were stored at Ϫ80°C until analysis. Plasma was obtained by centrifugation, and lipoproteins were separated by FPLC. 25 Triglyceride levels were measured with enzymatic methods (Boehringer Mannheim). OxLDL in plasma was measured with a monoclonal antibody (mAb) 4E6-based ELISA (please see the supplemental materials, available online at http:// atvb.ahajournals.org). 26 TNFalpha was measured with a specific porcine ELISA (R&D Systems). Total sPLA2 enzymatic activity was determined using 3H-oleoyl radiolabeled E. coli membranes. 27 PAFAH activity was defined as described in the supplemental materials. Because recent studies suggest that the native activity of PON1 is not esterase but lactonase, 28 we defined PON1 activity as its lactonase activity. This was measured as the hydrolysis of 5-thiobutyl butyrolactone (TBBL) in serum. 29 LPC was measured with an enzymatic colorimetric assay (Cosmo Bio Co.).
Analysis of Plaques
The extent of atherosclerosis was determined by analysis of 18 cross-sections, spanning a 3-mm segment, of the proximal left anterior descending artery (LAD). Sections were analyzed using the Leica Quantimet 600 (Leica). 21, 22, 24, 30 Lipid deposition was determined on oil red O-stained sections. Macrophages were stained with an anti-CD18 antibody, oxLDL, with 4E6, 31 smooth muscle cells (SMCs) with an anti-␣-SM actin monoclonal antibody, and PAFAH with a custom made polyclonal rabbit antibody (Proteogenix) directed to the polypeptide PVAHMKSSAWVNKIQVL and recognizing both the human and porcine N-terminal part of PAFAH. PON1 was stained using a polyclonal antibody directed against a synthetic peptide derived from a specific sequence of mature PON1 and ApoA1 was detected with a murine monoclonal antibody to human ApoA1. 32, 33 We used the DakoCytomation Envisionϩ System-HRP to reduce nonspecific binding. 30 Isolation of porcine blood monocytes and coronary plaque macrophages, culture, and oxLDL-induced stimulation of THP1 and human monocyte-derived macrophages, total RNA extraction, and quantitative real-time PCR (qRT-PCR) analysis were all performed according to previously described protocols 21, 30 (please see the supplemental materials).
Statistical Analysis
Groups were compared by the Mann-Whitney U test with statistical significance defined at a value of PϽ0.05. Spearman rank correlation coefficient was determined with Graph Pad Prism version 5.0.
Results
Effect of Atherogenic Diet on Blood Variables
The high-fat diet induced an increase of total, LDL, and HDL cholesterol. Triglycerides and TNFalpha tended to be higher, but the increase was not significant. Total sPLA2 activity and PON1 activity were higher in the serum of diet-fed pigs as compared to controls (Table 1A ). The plasma PAFAH activity increased with the duration of diet feeding ( Figure  1A ) and was associated with an increase in LPC ( Figure 1B ) and oxLDL ( Figure 1C ). In diet-fed pigs, plasma PAFAH activity correlated with plasma levels of oxLDL ( Figure 1D ). In addition to increasing the total PAFAH activity, dietfeeding also changed the lipoprotein distribution of PAFAH. In control pigs, almost 90% of PAFAH activity was associated with HDL, and 5% was associated with LDL. In diet-fed pigs, the LDL-associated PAFAH activity increased to 17%, whereas 74% remained associated with HDL. A minor portion was recovered in the VLDL fraction. The PAFAH/ PON1 ratio, defined as PAFAH activity divided by PON1 activity, in diet-fed pigs was 322Ϯ122 compared to 67Ϯ44 in control pigs (PϽ0.0001). In vitro cell experiments demonstrated that oxLDL induced PLA2G7 mRNA expression in THP1 monocytes with 174% and to a larger extent in THP1 macrophages ( Figure 1E ). OxLDL also induced the expression of PLA2G7 in human monocyte-derived macrophages ( Figure 1F ). 
Effect of Atherogenic Diet on Plaque Volume and Plaque Composition
Table 1B summarizes the total plaque size and the macrophage, lipid, oxLDL, and SMC content of the coronary plaques. On average, macrophages, together with lipids and oxLDL, accounted for 35% of the total plaque area and SMCs accounted for 62%. Figure 2 shows immunohistochemical staining of macrophages (Figure 2A ), PAFAH protein ( Figure 2B ), and oxLDL ( Figure 2C ) in overlapping areas on adjacent sections. We demonstrated colocalization of PON1 protein ( Figure 2D ) and HDL-associated ApoA1 ( Figure 2E ). Figure 2F shows a section to which no specific primary antibody was added.
Relation Between PLA2G7 Expression, PAFAH Activity, and Inflammation and Atherosclerosis
To determine why PAFAH activity was increased in the blood of diet-fed pigs, we measured the expression of genes coding for different phospholipases in blood monocytes and plaque macrophages. Table 2 shows that only the RNA expression of PLA2G7 (PAFAH) was increased in monocytes and plaques macrophages in diet-fed pigs. PLA2G7 expression in plaque macrophages ( Figure 3A ) correlated significantly with the activity of its secreted product, PAFAH, in the blood ( Figure 3B ). The expressions of PLA2G10, PAFAH2, PLA2G4A, PAFAH1B1, PAFAH1B2, and PAFAH1B3 were not altered by diet. RNA expressions of secreted PLA2s PLA2G2A, PLA2G3, and PLA2G5 could not be reliably measured by qRT PCR because of inefficient amplification because of very low expression. Interestingly, PLA2G7 expression was already higher in monocytes of diet-fed pigs as compared to controls ( Figure 3A) . Its expression was also increased in the liver of diet-fed pigs (ratio versus liver of control pigs: 3.5Ϯ1.3), but it did not correlate with plasma activity.
To determine the relation between increased PAFAH and inflammation, we measured the RNA expressions of proinflammatory TLR2, IRF1, and TNFalpha. Their expressions were all significantly higher in monocytes and macrophages of diet-fed Figure 1 . The effect of diet-induced hypercholesterolemia on plasma PAFAH activity, LPC, and oxLDL levels. PAFAH activity correlates with oxLDL in circulation and oxLDL induces PLA2G7 expression in THP1 macrophages and human monocyte-derived macrophages in vitro. PAFAH activity increased with the duration of cholesterol-rich diet feeding (A). As expected, this increase was associated with an increase in LPC (B). In addition, it was also associated with an increase in oxLDL (C). In diet-fed pigs, PAFAH activity in blood correlated with circulating oxLDL (D). OxLDL increased PLA2G7 RNA expression in THP1 macrophages incubated with oxLDL (E). Expression of PLA2G7 also increased in human monocyte-derived macrophages incubated with oxLDL (F). Data are meanϮSD; *PϽ0.05, **PϽ0.01, ***PϽ0.001 compared to control; $PϽ0.05 compared to 6-week diet-fed pigs. Rs indicates Spearman correlation coefficient. Figure 2 . PAFAH protein in coronary plaques is associated with macrophages and oxLDL. Adjacent cryosections were immunostained (brown) with antibodies specific for macrophages (A), plaque PAFAH (B), plaque oxLDL (C), plaque PON1 (D), and plaque ApoA1 (E). Unspecific staining was determined using sections to which no specific primary antibody was added (F).
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pigs as compared to control pigs ( Table 2) . PAFAH correlated positively with TNFalpha expression in macrophages ( Figure  3C ) but not in monocytes. Furthermore, PAFAH correlated also positively with plaque size ( Figure 3D ). The gene expressions of PON1 (ratio versus control: 0.88Ϯ0.41), PON2 (0.88Ϯ0.27), and PON3 (0.68Ϯ0.34) were lower in diet-fed pigs, but differences were not significant.
Discussion
As in earlier studies, we found that hypercholesterolemia in pigs is associated with an increase of plasma PAFAH. 34 As in humans, PAFAH activity was positively related to atherosclerotic plaque size. The main source of PAFAH activity in the blood were plaque macrophages, 35, 36 suggesting that the increase in PAFAH activity in the blood is a consequence rather than a cause of the accumulation of macrophages in the plaques. However, increased expression of PLA2G7 (coding for PAFAH) in plaque macrophages was associated with increased proinflammatory gene expression, 34, 37 which contributes to atherosclerosis. An important novel finding of our study was that oxLDL induced PLA2G7 expression in monocytes and macrophages in vitro, supporting the correlation between PAFAH activity and oxLDL in blood. Moreover, the increase in PAFAH activity was associated with an increased release of LPC, a major phospholipid component of oxLDL that is critically implicated in the atherogenicity of oxLDL 38 by enhancing inflammation. 30 Before, it had been noted in humans that subjects with pattern B LDL, who have a proatherogenic lipoprotein profile, have increased PAFAH activity compared with normal pattern A LDL subjects. 39 The observed shift of PAFAH from HDL to LDL in diet-fed pigs is important in view of our recent finding that PAFAH and LDL oxidation products are present on the same LDL particles, 40 supporting the hypothesis that accumulation of LPC increases the inflammatory action of oxLDL. Our cell experiments support the hypothesis that oxLDL induces the expression of the PAFAH gene, thereby increasing levels of inflammatory LPC. Moreover, RNA expressions of PLA2G7 and of the proinflammatory genes were already increased in circulating monocytes, further supporting the activation of these cells before infiltration. Interestingly, we did not observe an increase of other phospholipases in circulating monocytes or plaque macrophages of hypercholesterolemic pigs.
Increased PAFAH activity correlated with plaque size and the expression of proinflammatory genes in coronary plaque macrophages. This is explained by the ability of PAFAH to produce key proinflammatory lipid mediators such as LPC on degradation of oxidized phospholipids generated during LDL oxidation. It has been shown previously that LPC induces the expression of several inflammatory cytokines 34 and that PAFAH contributes to LPC accumulation in situ, 41 although, in our study, LPC measurements in aortic homogenates were below the detection limit of the assay.
As in humans, our data show a positive association between an increase in PAFAH and coronary atherosclerosis. However, they are in conflict with previous mouse data showing an antiatherogenic effect of PAFAH. One possible explanation is that in pigs the increase in HDL cholesterol is associated with an increase of the PAFAH to HDL cholesterol ratio but not of the PON1 to HDL ratio, resulting in a higher PAFAH to PON1 ratio. In mice, increases of HDL in ApoE Ϫ/Ϫ mice were associated with increases of both the PAFAH and PON1 to HDL ratios, thereby leading to an inhibition of atherosclerosis. 42 In contrast, an increase of PAFAH in the absence of an increase in PON1, resulting in a higher PAFAH to PON1 ratio in a mouse model of the metabolic syndrome 43 was associated with increased accumulation of oxLDL and accelerated atherosclerosis. Moreover, when PON1 was overexpressed in these mice, the decrease of the PAFAH to PON1 ratio was associated with decreased accumulation of oxLDL and inhibition of atherosclerosis. 44 Although we showed here the colocalization of PON1 protein and the HDL-specific ApoA1 in plaques, their accumulation did not prevent atherosclerosis. This is surprising in view of the recent finding that overexpression of the whole PON gene cluster had no additive effect on atherosclerosis compared to the overexpression of the single PON1 transgene in mice. 45 Because our pigs have very low CETP activity, our data are also important in view of the negative outcome of the clinical trial with torcetrapib, a CETP inhibitor. 46 Despite significant increases in HDL cholesterol levels, the majority of the torcetrapib-treated patients demonstrated no regression of coronary atherosclerosis. This supports the notion that the protective properties of HDL particles depend on HDL associated activities rather than on HDL cholesterol levels. 47 At this point we cannot exclude that PAFAH is inactivated in the vessel wall. Studies have demonstrated the susceptibility of PAFAH to oxidative attack. 48 However, a recent study showed a significant increase of arterial PAFAH activity in diabetic and hypercholesterolemic pigs that was normalized after treatment with the PAFAH inhibitor Darapladib. 37 In addition, PAFAH in situ was catalytically active in Watanabe rabbits 49 and in humans. 50 In conclusion, we demonstrated for the first time an association between blood oxLDL and an increase in PAFAH activity in hypercholesterolemic minipigs. This association was further supported by the observation that oxLDL induced the PAFAH gene expression in THP1 and human bloodderived macrophages. The increase in PAFAH was associated with an increase in LPC, increased expression of proinflammatory genes in coronary plaque macrophages, and with the progression of atherosclerosis.
